Skip to content

Biodesix, Inc. BDSX Price / book

Price / book at other companies

NeoGenomics logo
NeoGenomicsNEO
1.2×-0.2×
Veracyte logo
VeracyteVCYT
1.9×0.0×
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
9.9×+4.1×
Personalis, Inc. logo
Personalis, Inc.PSNL
2.6×+1.1×
Guardant Health logo
Guardant HealthGH
36.8×
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
19.4×-6.1×

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Calculated from Biodesix, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s price / book?
Biodesix, Inc. (BDSX) reported price / book of 15.7× in Q1 2026.
How has Biodesix, Inc.'s price / book changed year-over-year?
Biodesix, Inc.'s price / book increased by 89.7% year-over-year, from 8.3× to 15.7×.
What is the long-term trend for Biodesix, Inc.'s price / book?
Over 4 years (2020 to 2024), Biodesix, Inc.'s price / book has grown at a -4.9% compound annual growth rate (CAGR), from 13× to 10.7×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.